Over a decade ago, the gene STT3 was identified in a staurosporine and temperature sensitivity screen of yeast. Subsequently the product of this gene was shown to be a subunit of the endoplasmic reticulum-localized oligosaccharyl transferase (OT) complex. Although stt3 mutants are known to be staurosporine-sensitive, we found that mutants of other OT subunits (except ost4∆) are staurosporine-resistant, which indicates that this phenotype of stt3 mutants is not simply a consequence of their defect in glycosylation, as previously speculated. Staurosporine sensitivity was found to be an allele-specific phenotype restricted to cells harboring mutations in highly conserved residues in the N-terminal domain of the STT3 protein. Cells bearing mutations in one of the cytosolic-oriented loops (aa 158-168) in the N-terminus of Stt3p were found to be specifically susceptible to staurosporine. Staurosporine is a specific inhibitor of Pkc1p, and a genetic link had previously been suggested between P K C 1 and STT3. It is known that overexpression of PKC1 suppresses the staurosporine sensitivity of the stt3 mutants in an allelespecific manner, which is typical of mutants of Pkc1p cascade. It has been shown that the pkc1 null mutant exhibits lowered OT activity. Our results combined with these previous observations indicate that the N-terminal domain of Stt3p may interact with members of the Pkc1p cascade and consequently mutations in this domain result in staurosporine sensitivity. We further speculate that the Pkc1p regulates OT activity through the N-terminal domain of Stt3p, the C-terminal domain of which possesses the recognition and/or catalytic site of the OT complex.
INTRODUCTION
A number of S T T (staurosporine-and temperature-sensitive) genes were identified during the staurosporine and temperature sensitivity screening in Saccharomyces cerevisiae (1) .
The protein product of one of the genes so identified, STT3 was later found to be a subunit of the oligosaccharyl transferase (OT) enzyme complex that functions to catalyze N-glycosylation in the ER lumen (2, 3) . Stt3p is a multi-transmembrane protein of 718 amino acids that is predicted to have a signal sequence, a hydrophobic N-terminal domain that spans the membrane several times and a hydrophilic C-terminal domain found to be lumenally oriented (3) (http://psort.nibb.ac.jp).
Stt3p is highly conserved in eukaryotes and is essential for the vegetative growth of yeast cells (2, 3) . A protein with high similarity has been identified in archaea and cloned from the grampositive bacteria Campylobacter jejuni (4) . Human, murine and Drosophila melanogaster proteins as well as a putative protein from Caenorhabditis elegans are more than 50% identical in amino acid sequence (2, 3) . It is noteworthy that the striking level of homology between the different Stt3p homologs is observed throughout the entire sequence of the protein. The role of the C-terminal domain of Stt3p in N-glycosylation is well established (5, 6) , however the functional significance of the highly conserved N-terminal domain is not known.
The molecular basis for the identification of STT3 gene in the staurosporine and temperature sensitivity screen is unclear because staurosporine is a potent inhibitor of protein kinase C (PKC) (7, 8) , which is localized in the cytosol (9, 10) . Since glycosylation is linked to cell wall biosynthesis (11) (12) (13) (14) (15) and Pkc1p is a central regulatory element in the biosynthesis of the yeast cell wall (16), it is assumed that staurosporine sensitivity of the stt3 mutants is a consequence of their glycosylation defect (3) . However, some prior observations suggest otherwise: a) Addition of 1M sorbitol or overexpression of PKC1 suppresses the staurosporine sensitivity of stt3 mutants in an allele-specific manner (2) , which is typical of mutants of genes involved in the PKC1 pathway in yeast. b) The stt3-3 mutation (T85I) results in a synthetic phenotype in combination with the ∆pkc1 mutation (3). c) The stt3stt1 double mutant is more sensitive to staurosporine that any of the single mutants (2) . All these observations are suggestive of a genetic link between STT3 and PKC1 (2).
Pkc1p is known to control several important cellular processes including cell cycle and cellular integrity (for a review, see 17). A potential role of Pkc1p in regulation of OT activity has been previously proposed by our lab since novel interaction of the lumenal domain of several OT subunits with Pkc1p were identified in a two-hybrid study (18). However the significance of this interaction is unclear since Pkc1p is a cytoplasmic protein (9, 10) and the domains of the OT subunits tested are lumenal [for reviews on OT see (19-21)]. The work described in this paper involving analysis of OT subunit mutants, besides that of several stt3 mutants suggests that staurosporine sensitivity of stt3 mutants is not a direct consequence of their glycosylation defect as previously speculated (3) . Based on our observations and those from other labs, we hypothesize that the N-terminal domain of Stt3p interacts with members of the Pkc1p cascade and that mutations in this domain result in hypersensitivity to staurosporine and thereby lethality in the presence of the drug. This led us to propose that Pkc1p cascade controls N-glycosylation by regulation of Stt3p activity.
MATERIALS AND METHODS
Yeast Strains, Media and Materials: Yeast strains used in this study are listed in Table I. 7 the subunits that are products of essential genes, we studied strains bearing temperature-sensitive alleles that are known to result in a severe glycosylation defect. As shown in Figs. 1A and B, only the stt3-1, stt3-2 mutants and the deletion strain of ost4 were found to be staurosporine-sensitive.
It is noteworthy that even the wbp1-2 or the ost2-3 mutant strains do not exhibit staurosporine sensitivity, although these mutations exhibit severe glycosylation defect (30, 31). Mutants of swp1 were not tested in this study due to their unavailability. The hygromycin B-sensitive phenotype is common to a large number of yeast mutants with a variety of glycosylation defects and therefore for comparison, we examined the hygromycin B sensitivity of the OT mutants. (33).
As shown in Fig. 1C , all the OT mutants were found to be hygromycin-sensitive to varying degrees. Thus of the mutants tested above, only the deletion strain of ost4 and the stt3 mutant strains exhibited staurosporine sensitivity. Stt3p and Ost4p are known to exist in one subcomplex of OT (26, 34).
Mutation in the N-terminal domain of Stt3p lead to staurosporine sensitivity:
Staurosporine is an inhibitor of Pkc1p (7, 8) . Because none of the OT subunit mutants exhibit staurosporine sensitivity except the stt3 mutants and the ost4 deletion strain, we examined the basis of staurosporine sensitivity of stt3 mutants. We carried out sequencing of the two mutant alleles stt3-1 and stt3-2 that were previously identified in the staurosporine sensitivity screening (1) using the primers listed in Table II . Sequencing of stt3-1 allele identified a point mutation at residue 163 converting G to R, and in the stt3-2 allele, two point mutations were found converting G210D and V393I. Thus both of the alleles bear mutations in the N-terminal domain of the protein (see Fig. 2 ). The stt3-1 mutation is known to result in a very severe growth and glycosylation defect, and a staurosporine-sensitive phenotype, which cannot be suppressed by over-expression of PKC1 (2) . Since the 163 rd residue is predicted to be a part of a cytosoloriented loop (aa 158-168) (SRSVAGSYDNE) between the first and the second transmembrane domain and is conserved with 100% identity among all of the known Stt3p homologs from yeast to human, we proceeded in a step-wise manner to mutate each residue in this loop (Fig. 2) . We mutated all the polar residues (S158, R159, S160, S164, Y165, D166, N167 and E168) to alanine and non-polar amino acids (V161 and A162) to arginine. All the mutant plasmids (TRP) were generated using a HA-epitope-tagged STT3 construct (pRS314-STT3-HA) as described under Materials and Methods. We examined if the TRP-plasmid borne mutant allele rescues the FOAsensitivity of stt3∆ strain harboring an URA plasmid-borne STT3 WT allele. We determined if any of the mutations resulted in a growth defect followed by examining their sensitivity to staurosporine. The results of growth phenotypes of the mutants are summarized in Table III and depicted in Fig. 2 . The mutant alleles R159A, S160A or S164A behave like the stt3-1 allele and lead to a temperature-and stauroporine-sensitive phenotype (Fig. 3) . Mutation of S158, V161, A162 or Y165 did not result in any obvious growth defect or staurosporine sensitivity. Y131A, Y211A or Y397A did not exhibit any growth defect or staurosporine-sensitivity whereas the other two mutations (W208A or R404A) resulted in a lethal phenotype. Of the two point mutations in the stt3-2 allele, we found that G210D but not V393I was responsible for the staurosporine and temperature sensitivity of this mutant allele (Fig. 3) .
The results thus far suggested that the mutations of many of the amino acids in the first cytosol-oriented loop (a.a.158-168) result in growth defect and staurosporine sensitivity. Since staurosporine is a specific inhibitor of Pkc1p (7, 8) , we examined the sequence of Stt3p for potential Pkc1p phosphorylation sites. However, mutation of the key Ser/Thr residue in three
Glycosylation-defective C-terminal domain mutants are staurosporine-resistant: We tested the staurosporine sensitivity of 4 lumenal domain mutants (W516A, Y519A, G520D and I593D) (Fig. 4) , which are known to cause both a severe growth defect and impairment of glycosylation (5) . In fact, three of the mutants possess point mutations in residues known to be involved in the peptide recognition and/or catalytic site of the protein (5). It is especially interesting that none of the lumenal domain mutants were staurosporine-sensitive (Fig. 4) . Thus it appears that staurosporine sensitivity is not a general consequence of any mutations affecting OT activity but a specific result of mutations of residues in a certain portion of Stt3p (3). Are the protein products of the mutant alleles that result in lethality incorporated in the OT complex?: Mutation of certain residues (D166A, N167A, E168A, W208A and R404A) result in a lethal phenotype, which could be explained in two ways: 1) these residues play an important role in the essential function of the protein; or 2) the protein products of these mutant alleles are not incorporated in the OT complex. To clarify this issue, we utilized strains bearing the TRP-plasmid borne HA-tagged mutant alleles whose viability was supported by an URA-plasmid borne untagged-wildtype allele. Following solubilization of the spheroplasts of the respective strains and immunoprecipitation of the HA-tagged mutant Stt3p, we examined whether Ost1p or Wbp1p co-immunoprecipitated by Western blotting. We found that the protein product from the mutant alleles D166A, N167A and E168A were incorporated into the OT complex (Fig. 6 ). This indicates that these three mutant alleles form a stable OT complex that is seriously impaired in OT activity, thus suggesting that these residues are functionally important. HA-tagged Stt3p from W208A and R404A did not coimmunoprecipitate Ost1p or Wbp1p (Fig. 6) indicating that in these mutants, the lethal phenotype is due to a defect in assembly of functional OT complex.
DISCUSSION
Several STT genes (STT1-10) were identified during the staurosporine and temperature sensitivity screen in yeast (1) . (2, 36) . Given that staurosporine is an inhibitor of Pkc1p (7, 8) , one asks why the STT3 gene was detected in the staurosporine screen. Since glycosylation is linked to cell wall biosynthesis (11) (12) (13) (14) (15) and Pkc1p is a central regulatory element in the biosynthesis of the yeast cell wall (16), it is assumed that staurosporine sensitivity of the stt3 mutants is a consequence of a cell wall defect possibly caused by underglycosylation of proteins (3) . Among all the staurosporine-and temperature-sensitive (STT) mutants isolated (1), only STT3 is known to be involved in the biosynthesis of Nglycoproteins (2, 3, 36) . This raises a question about the validity of the idea of attributing the staurosporine sensitivity of stt3 mutants to a general glycosylation defect (3) . Indeed, the current study indicates that the phenotypic consequence of staurosporine sensitivity of stt3 mutants is much more complicated than has been envisaged.
If a general glycosylation defect resulted in staurosporine sensitivity, one might assume that mutations in any of the OT subunits that are known to cause an underglycosylation defect should result in sensitivity to stauroporine. Among the various OT subunits tested, all but certain stt3 mutants and a ∆ost4 strain exhibited resistance to this drug. To acquire more insight into the mechanism underlying the staurosporine sensitivity of stt3 strains, the sequences of the two mutant alleles stt3-1 and stt3-2, that had been identified in staurosporine screen (1, 2) were determined. Both mutations were found to be located in the highly conserved residues in the Nterminal hydrophobic domain of the protein (See Fig. 2 ). The stt3-1 mutant allele, which bears a point mutation G163R, as noted earlier is a part of the first cytosol-oriented loop that is completely conserved among Stt3p homologs from 6 species ranging from yeast to human. Site- Thus the data obtained in this study clearly suggest that the glycosylation activity of Stt3p is dependent on the Pkc1p cascade. This hypothesis explains the previously observed genetic link between STT3 and PKC1 (2) . In this respect, it is important to re-mention the two-hybrid screen carried out with the lumenally oriented C-terminal domain of the Stt3p, which was found to interact with none of the other OT subunits, but with Pkc1p (18). Since Pkc1p has not been identified in the ER lumen, the results of this two-hybrid study have been ignored. However, the present study suggests that the previously observed genetic and two-hybrid interaction between Stt3p and Pkc1p may have functional significance. Careful investigation for a possible isoform of Pkc1p and its effect on glycosylation needs to be carried out.
14. Page, N., Gerard-Vincent, M., Menard, P., Beaulieu, M., Azuma, M., Dijkgraaf, G. Table I were diluted serially and spotted on following plates -YPD (A), YPD+staurosporine (1 µg/ml) (B) or YPD+hygromycin B (50 µg/ml) (C). All plates were incubated at 25 °C. After three days the growth of colonies was compared. QYY700-1 was transformed with TRP plasmid containing the respective HA-tagged WT or stt3 mutant allele (as indicated in the figure). Spheroplasts from each strain were subjected to nondenaturing immunoprecipitation using mouse anti (HA) antibody as described under Materials and Methods. Equal amounts of each sample that had been eluted from protein G-agarose were analyzed by SDS-PAGE, followed by Western blotting using the following polyclonal antisera raised in rabbit at the dilutions mentioned in parentheses: anti (HA) (1:3000); anti (Ost1p)
(1:5000); and anti (Wbp1p) (1:5000). The HRP-conjugated secondary anti-rabbit antibody was used at a dilution of 1:3000. -+ All point mutants were generated with pRS314-STT3-HA as a template. The resulting plasmid bearing the expected point mutation was transformed into QYY700-1 and subjected to FOA selection at 25 °C. L stands for lethal phenotype, + indicates that growth was observed andindicates that no growth was observed. ST stands for staurosporine that was used at a concentration of 1 µg/ml in YPD media. Mutations resulting in staurosporine and temperature sensitive phenotype are indicated in bold. a The stt3-1 and stt3-2 mutations were identified in the temperature and staurosporine sensitivity screen (Ref. 
